Search:

Practical and Theoretical Radiotherapy Physics Courses

Course overview

This course provides practical and theoretical education for the support of a modern radiotherapy physics service within radiotherapy.

It is aimed primarily at recently qualified radiotherapy physicists, but should also be invaluable to post-graduate students, researchers, clinical oncologists, engineers, radiographers, manufacturers’ representatives and in fact, anyone needing to deepen or update their understanding of this rapidly evolving field.

The faculty is composed of physicists, clinicians and radiographers, many of whom are internationally renowned for their expertise. Workshops and demonstrations make full use of the facilities of the Radiotherapy and Physics Departments of The Royal Marsden NHS Foundation Trust. The course content is reviewed annually to reflect changes in practice and technology.

Course details

3-7 November 2026: the course in November will be held at our Sutton Site

Programme Nov 2026

RT 2026 Registration

Programme March 2027

Course fees

The cost for one week is £800.00. For those wishing to book the complete two weeks, the cost is discounted to £1,350.

External, full-time PhD students with proof of academic registration can book the eight lecture days of both weeks for a discounted price. Please contact the course secretary for this.

For registration details you can email our course secretary.

Contacts

Further details on course content can be obtained from the course organisers:

Margaret Bidmead

Tel: +44 (0)20 7808 2506

Fax: +44 (0)20 7808 2522

Dr Michael Thomas

Tel: +44 (0)20 8661 3475

Fax: +44 (0)20 8643 3812

Latest ICR News

Hand holding magnifying lens pointing at group of different coloured illustrated figures

Cancer trials under the microscope: Study finds barriers to inclusion persist in the UK

08/06/26

A new UK-based study is shedding light on a quiet but consequential problem in cancer research: whether some people have less opportunity than others to participate in clinical trials.

Image of immunofluorescence staining of bladder tumour tissue. Some areas appear lighter green, some dark blue, and others black.

Immunotherapy boost can spare more bladder cancer patients major surgery

02/06/26

An immunotherapy helps bladder cancer patients remain cancer free and enables them to avoid surgery, a phase II trial has found.

Histopathologic image illustrating squamous cell carcinoma.

Immunotherapy injection shrinks tumours in patients with recurrent and/or metastatic head and neck cancer

31/05/26

A targeted cancer treatment given via a simple injection under the skin shrank tumours in more than one third of patients with recurrent and/or metastatic head and neck cancer whose disease has stopped responding to standard treatments, according to research led by scientists at The Institute of Cancer Research, London

Image of pill bottle with pills spilling out

New targeted therapy shrinks advanced gastrointestinal tumours for 61 per cent of patients in an early study

30/05/26

A new, targeted cancer therapy for advanced gastrointestinal stromal tumours (GIST) has shown promising early results, with 61 per cent of patients who received velzatinib as first-line treatment experiencing tumour shrinkage of 30 per cent or over. The results could pave the way for a larger trial to evaluate this therapy as a first-line alternative to imatinib, which has been the standard treatment for more than two decades.